Additionally, in an open-label trial of patients with psoriatic arthritis, pioglitazone reduced both tender and swollen joint counts[26], and pioglitazone decreased CRP and serum amyloid A and improved insulin sensitivity in patients with uncomplicated systemic lupus erythematosus[27]. The gene discussed is INS; the disease is systemic lupus erythematosus.